These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 22005315)

  • 1. [Comment on "Duration of treatment with nonsteroidal anti-inflammatory drugs and impact on risk of death and recurrent myocardial infarction in patients with prior myocardial infarction. A Nationwide Cohort Study].
    Mimoso J
    Rev Port Cardiol; 2011 Jul; 30(7-8):689-90. PubMed ID: 22005315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duration of treatment with nonsteroidal anti-inflammatory drugs and impact on risk of death and recurrent myocardial infarction in patients with prior myocardial infarction: a nationwide cohort study.
    Schjerning Olsen AM; Fosbøl EL; Lindhardsen J; Folke F; Charlot M; Selmer C; Lamberts M; Bjerring Olesen J; Køber L; Hansen PR; Torp-Pedersen C; Gislason GH
    Circulation; 2011 May; 123(20):2226-35. PubMed ID: 21555710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term cardiovascular risk of nonsteroidal anti-inflammatory drug use according to time passed after first-time myocardial infarction: a nationwide cohort study.
    Olsen AM; Fosbøl EL; Lindhardsen J; Folke F; Charlot M; Selmer C; Bjerring Olesen J; Lamberts M; Ruwald MH; Køber L; Hansen PR; Torp-Pedersen C; Gislason GH
    Circulation; 2012 Oct; 126(16):1955-63. PubMed ID: 22965337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ongoing treatment with non-steroidal anti-inflammatory drugs at time of admission is associated with poorer prognosis in patients with first-time acute myocardial infarction.
    Lamberts M; Fosbøl EL; Olsen AM; Hansen ML; Folke F; Kristensen SL; Olesen JB; Hansen PR; Køber L; Torp-Pedersen C; Gislason GH
    Int J Cardiol; 2013 Sep; 168(2):832-7. PubMed ID: 23117013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of NSAID use with risk of bleeding and cardiovascular events in patients receiving antithrombotic therapy after myocardial infarction.
    Schjerning Olsen AM; Gislason GH; McGettigan P; Fosbøl E; Sørensen R; Hansen ML; Køber L; Torp-Pedersen C; Lamberts M
    JAMA; 2015 Feb; 313(8):805-14. PubMed ID: 25710657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased mortality and cardiovascular morbidity associated with use of nonsteroidal anti-inflammatory drugs in chronic heart failure.
    Gislason GH; Rasmussen JN; Abildstrom SZ; Schramm TK; Hansen ML; Fosbøl EL; Sørensen R; Folke F; Buch P; Gadsbøll N; Rasmussen S; Poulsen HE; Køber L; Madsen M; Torp-Pedersen C
    Arch Intern Med; 2009 Jan; 169(2):141-9. PubMed ID: 19171810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction.
    Gislason GH; Jacobsen S; Rasmussen JN; Rasmussen S; Buch P; Friberg J; Schramm TK; Abildstrom SZ; Køber L; Madsen M; Torp-Pedersen C
    Circulation; 2006 Jun; 113(25):2906-13. PubMed ID: 16785336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NSAIDs are associated with increased risk of atrial fibrillation in patients with prior myocardial infarction: a nationwide study.
    Schjerning Olsen AM; Fosbøl EL; Pallisgaard J; Lindhardsen J; Lock Hansen M; Køber L; Hansen PR; Torp-Pedersen C; Gislason GH
    Eur Heart J Cardiovasc Pharmacother; 2015 Apr; 1(2):107-14. PubMed ID: 27533979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NSAID use and association with cardiovascular outcomes in outpatients with stable atherothrombotic disease.
    Kohli P; Steg PG; Cannon CP; Smith SC; Eagle KA; Ohman EM; Alberts MJ; Hoffman E; Guo J; Simon T; Sorbets E; Goto S; Bhatt DL;
    Am J Med; 2014 Jan; 127(1):53-60.e1. PubMed ID: 24280110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cause-specific cardiovascular risk associated with nonsteroidal anti-inflammatory drugs among myocardial infarction patients--a nationwide study.
    Olsen AM; Fosbøl EL; Lindhardsen J; Andersson C; Folke F; Nielsen MB; Køber L; Hansen PR; Torp-Pedersen C; Gislason GH
    PLoS One; 2013; 8(1):e54309. PubMed ID: 23382889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time-perspective in cardiovascular risk of NSAID use after first-time myocardial infarction.
    Olsen AM; Gislason GH; Fosbøl EL
    Curr Opin Cardiol; 2013 Nov; 28(6):683-8. PubMed ID: 24077606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs in high doses increases mortality and risk of reinfarction in patients with prior myocardial infarction.
    Sørensen R; Abildstrom SZ; Torp-Pedersen C; Gislason GH
    J Cardiovasc Nurs; 2008; 23(1):14-9. PubMed ID: 18158501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of myocardial infarction and death associated with the use of nonsteroidal anti-inflammatory drugs (NSAIDs) among healthy individuals: a nationwide cohort study.
    Fosbøl EL; Gislason GH; Jacobsen S; Folke F; Hansen ML; Schramm TK; Sørensen R; Rasmussen JN; Andersen SS; Abildstrom SZ; Traerup J; Poulsen HE; Rasmussen S; Køber L; Torp-Pedersen C
    Clin Pharmacol Ther; 2009 Feb; 85(2):190-7. PubMed ID: 18987620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular risks of nonsteroidal antiinflammatory drugs in patients after hospitalization for serious coronary heart disease.
    Ray WA; Varas-Lorenzo C; Chung CP; Castellsague J; Murray KT; Stein CM; Daugherty JR; Arbogast PG; García-Rodríguez LA
    Circ Cardiovasc Qual Outcomes; 2009 May; 2(3):155-63. PubMed ID: 20031832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NSAID use and the risk of hospitalization for first myocardial infarction in the general population: a nationwide case-control study from Finland.
    Helin-Salmivaara A; Virtanen A; Vesalainen R; Grönroos JM; Klaukka T; Idänpään-Heikkilä JE; Huupponen R
    Eur Heart J; 2006 Jul; 27(14):1657-63. PubMed ID: 16731535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis after first-time myocardial infarction in patients with inflammatory bowel disease according to disease activity: nationwide cohort study.
    Kristensen SL; Ahlehoff O; Lindhardsen J; Erichsen R; Lamberts M; Khalid U; Nielsen OH; Torp-Pedersen C; Gislason GH; Hansen PR
    Circ Cardiovasc Qual Outcomes; 2014 Nov; 7(6):857-62. PubMed ID: 25316773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis following first-time myocardial infarction in patients with psoriasis: a Danish nationwide cohort study.
    Ahlehoff O; Gislason GH; Lindhardsen J; Olesen JB; Charlot M; Skov L; Torp-Pedersen C; Hansen PR
    J Intern Med; 2011 Sep; 270(3):237-44. PubMed ID: 21362070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of ST versus non-ST elevation myocardial infarction associated with non-steroidal anti-inflammatory drugs.
    Grimaldi-Bensouda L; Rossignol M; Danchin N; Steg PG; Bessede G; Ovize M; Cottin Y; Autret-Leca E; Benichou J; Abenhaim L;
    Heart; 2011 Nov; 97(22):1834-40. PubMed ID: 21880652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study.
    Johnsen SP; Larsson H; Tarone RE; McLaughlin JK; Nørgård B; Friis S; Sørensen HT
    Arch Intern Med; 2005 May; 165(9):978-84. PubMed ID: 15883235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the varied use of NSAIDs explain the differences in the risk of myocardial infarction?
    van Staa TP; Rietbrock S; Setakis E; Leufkens HG
    J Intern Med; 2008 Nov; 264(5):481-92. PubMed ID: 18624902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.